Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system

Gene Therapy

Volumn 7, Issue 7, 2000, Pages 548-555

  Nishikawa, M ^a,b   Yamauchi, M ^a   Morimoto, K ^a   Ishida, E ^a   Takakura, Y ^a   Hashida, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Asialoglycoprotein receptor; Fusigenic peptide; Galactose; Gene delivery system; Hepatocyte; In vivo gene transfer

Indexed keywords

ALBUMIN; ASIALOGLYCOPROTEIN RECEPTOR; FLUORESCEIN; GALACTOSE; LIPOSOME; LUCIFERASE; PEPTIDE; PLASMID DNA; POLYORNITHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENDOSOME; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; LIVER CELL; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ANIMALIA; EUKARYOTA;

EID: 0034104640     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301140     Document Type: Article

References (43)

1. Anderson WF. Human gene therapy. Nature 1998; 392 (Suppl.): 25-30.
2. Mahato RI, Takakura Y, Hashida M. Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations. Crit Rev Ther Drug Carrier Syst 1997; 14: 133-172.
3. Lee RJ, Huang L. Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst 1997; 14: 173-206.
4. Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6: 1129-1144.
5. Curiel DT et al. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA 1991; 88: 8850-8854.
6. Cristiano RJ, Smith LC, Woo SLC. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci USA 1993; 90: 2122-2126.
7. Wu GY et al. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of the original receptor specificity and enhances targeted gene expression. J Biol Chem 1994; 269: 11542-11546.
8. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989; 243: 375-378.
9. Kato K et al. Expression of hepatitis B virus surface antigen in adult rat liver. Co-introduction of DNA and nuclear protein by a simplified liposome method. J Biol Chem 1991; 266: 3361-3364.
10. Pinnaduwage P, Schmitt L, Huang L. Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells. Biochem Biophys Acta 1989; 985: 33-37.
11. Wagner E et al. Influenza virus hemagglutinin HA-2 N-terminal fusigenic peptides augment gene transfer by transferrin-polylysine/DNA complexes: towards a synthetic virus-like gene transfer vehicle. Proc Natl Acad Sci USA 1992; 89: 7934-7938.
12. Gottschalk S et al. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Therapy 1996; 3: 448-457.
13. Plank C et al. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 1994; 269: 12918-12924.
14. Wu GY, Wu CH. Gene therapy by targeting nucleic acids to hepatocytes. In: Arias IM et al (eds). The Liver: Biology and Pathobiology, third edition. Raven Press: New York, 1994, pp 1537-1556.
15. Wilson JM. Round two for liver gene therapy. Nat Genet 1996; 12: 232-233.
16. Zhu N et al. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-211.
17. Song YK et al. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther 1997; 8: 1585-1594.
18. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Therapy 1997; 4: 891-900.
19. Mahato RI et al. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. J Drug Targeting 1995; 3: 149-157.
20. 32P-DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. J Pharm Sci 1996; 85: 612-618.
21. Hara T, Tan Y, Huang L. In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector. Proc Natl Acad Sci USA 1997; 94: 14547-14552.
22. Budker V et al. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Therapy 1996; 3: 593-598.
23. Ledley FD et al. Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions. Proc Natl Acad Sci USA 1987; 84: 5335-5339.
24. Ferry N et al. Retrovirus-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA 1991; 88: 8377-8381.
25. Grossman M et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994; 6: 335-341.
26. Wu GY, Wu CH. Receptor-mediated in vitro gene transfections by a soluble DNA carrier complexes. J Biol Chem 1986; 262: 4429-4432.
27. Wu CY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1991; 263: 14621-14624.
28. Perales JC et al. Biochemical and functional characterization of DNA' complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor. J Biol Chem 1997; 272: 7398-7407.
29. Perales JC et al. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-mediated uptake. Proc Natl Acad Sci USA 1994; 91: 4086-4090.
30. Nishikawa M et al. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J Pharmacol Exp Ther 1998; 287: 408-415.
31. Hashida M et al. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). J Control Rel 1998; 53: 301-310.
32. Kawabata K, Takakura Y, Hashida M. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm Res 1995; 12: 825-830.
33. Nishikawa M et al. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties. Am J Physiol 1995; 268: G849-G856.
34. Nishikawa M et al. Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice. Int J Pharm 1992; 85: 75-35.
35. Bennett HS, Luft JH, Hampton JC. Morphological classification of vertebrate blood capillaries. Am J Physiol 1959; 196: 381-390.
36. Takakura Y et al. Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice. Pharm Res 1999; 16: 503-508.
37. Perales JC et al. An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. Eur J Biochem 1994; 226: 225-266.
38. Plank C, Zauner W, Wagner E. Application of membrane-active peptides for drug and gene delivery across cellular membranes. Adv Drug Delivery Rev 1998; 34: 21-35.
39. Liu Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol 1997; 15: 167-173.
40. Song YK, Liu F, Liu D. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. Gene Therapy 1998; 5: 1531-1537.
41. Löser P et al. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFκB. J Virol 1998; 72: 180-190.
42. Sambrook K, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: Plainview: New York, 1989.
43. Atherton E et al. The polyamide method of solid phase peptide and oligonucleotide synthesis. Bioorg Chem 1979; 8: 351-370.